JAK1 and JAK3 — Drug Target
All drugs that target JAK1 and JAK3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Tofacitinib (Xeljanz) · Pfizer · Janus Kinase Inhibitor · Immunology
All drugs that target JAK1 and JAK3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.